---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-23-006802"
form_type: "8-K"
ticker: null
cik: "0001726822"
company_name: "Soul Biotechnology Corp"
filed_at: "2023-10-27T23:59:59+00:00"
generated_at: "2026-06-09T07:09:02.137936+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Soul Biotechnology Corp. changes name to Adorbs Inc. effective Oct 24, 2023

## Summary
- Name changed from Soul Biotechnology Corp. to Adorbs Inc. via articles of amendment.
- Reason stated: to facilitate potential DTC eligibility for the common stock.
- Effective date of name change is October 24, 2023.
- Company states this reverts to its original corporate name.

## SEC filing metadata
- accession: 0001829126-23-006802
- form_type: 8-K
- cik: 0001726822
- company_name: Soul Biotechnology Corp
- filed_at: 2023-10-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726822/000182912623006802/0001829126-23-006802-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726822/000182912623006802/soulbiotechno_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-23-006802
- JSON: https://secwatch.observer/filing/0001829126-23-006802.json
- Plain text: https://secwatch.observer/filing/0001829126-23-006802.txt

## Key facts
- Governance Changes
  Soul Biotechnology Corp: Amended articles of incorporation to change company name from Soul Biotechnology Corp. to Adorbs Inc (effective 2023-10-24).
  - Change: charter amendment
  - Effective: 2023-10-24
  source text: On October 24, 2023, Soul Biotechnology Corp. (the “Company”), amended its articles of incorporation, changing its name to Adorbs Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726822/000182912623006802/0001829126-23-006802-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.